newsfilter
← Latest News
ACCESS Newswire·

Nasdaq Accepts NLS Pharmaceutics' Plan to Regain Listing Compliance

ZURICH, SWITZERLAND / ACCESSWIRE / March 11, 2024 / NLS Pharmaceutics Ltd. , a Swiss clinical-stage biopharmaceutical company focused on the